| 引用本文: | 黄亚天,陆涛.作用于多靶点的组蛋白去乙酰化酶抑制剂结构设计的研究进展[J].中国现代应用药学,2013,30(9):1037-1042. |
| HUANG Yatian,LU Tao.Progress in the Research of Structural Design in Multi-targeted Histone Deacetylase Inhibitors[J].Chin J Mod Appl Pharm(中国现代应用药学),2013,30(9):1037-1042. |
|
| 摘要: |
| 目的 肿瘤产生机制的复杂性，要求对多种促肿瘤发生发展机制同时抑制，才能有效阻止肿瘤生长。组蛋白去乙酰化酶抑制剂(HDACi)作为一种新型抗肿瘤药物，能诱导肿瘤细胞凋亡, 阻止癌细胞增长。利用结构的多样性和变通性设计新颖的作用于多靶点的HDACi。方法 分类总结大量已被报道的多靶点组蛋白去乙酰化酶抑制剂。结果 多靶点抑制剂在临床实验中表现出了较好的抗肿瘤活性。结论 多靶点单一分子的HDACi的研究日益引起人们的重视，具有广阔的研发前景。 |
| 关键词: 组蛋白去乙酰化酶抑制剂 多靶点抑制剂 抗肿瘤 研究进展 |
| DOI： |
| 分类号: |
| 基金项目: |
|
| Progress in the Research of Structural Design in Multi-targeted Histone Deacetylase Inhibitors |
|
HUANG Yatian, LU Tao
|
|
Organic Chemistry Staffroom, China Pharmaceutical University, Nanjing 210009, China
|
| Abstract: |
| OBJECTIVE The heterogeneous nature of cancer requires a comprehensive approach for attacking the multiple mechanisms underlying the initiation and progression of cancer. HDACi have emerged as a new class of anticancer agents, targeting the biological processes including cell cycle, apoptosis and differentiation. Design novel multi-target HDACi based on the structural diversity and adaptation. METHODS Classify and summarize large numbers of reported multi-target histone deacetylase inhibitors. RESULTS Multi-target inhibitors in clinical trials show good antitumor activity. CONCLUSION Multi-target single-molecule HDAC inhibitors have attracted much attention, and have broad prospects for development. |
| Key words: HDACi multi-targeted inhibitor cancer therapy research development |
